CAStem

N/A

Report date: 2024/07/12 16:33:13

Base Information

Drug NameCAStem
Drug Alias NameCAStem细胞注射液Human Embryonic Stem Cells Derived M Cells
ClassificationCell and gene therapy > Cell therapy > Source of cells > Embryonic stem cell-derivedCell and gene therapy > Cell therapy > Somatic cell > Immunity- and matrix-regulatory cells
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Meniscus InjuriesGraft vs Host Disease +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesInstitute Of Zoology, Chinese Academy Of Sciences
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesInstitute Of Zoology, Chinese Academy Of SciencesBeijing Zehui Chenxing Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMeniscus InjuriesGraft vs Host DiseaseRespiratory Distress Syndrome, Adult +[4] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Acute Lung InjuryPneumovirus Infections +[4] 

Other Information

ATC CodeN/A
Related LinksN/A